The Winter 2020 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and tests new treatments for non-small cell cancer in partnership with the National Cancer Institute, Foundation for the National Institutes of Health, and Friends of Cancer Research.

The newsletter gives a grateful accounting of progress made during this remarkable year, with over 900 study registrations. It also also includes links to the latest Lung-MAP manuscript, published in The Lancet Oncology, and a list of new study leaders. Read the newsletter here.

Other Recent Stories

SWOG Front Line banner
Mar 21, 2025
The S2212 de-escalation trial asks important questions the NCI's NCTN is uniquely qualified to answer
Team Hope rides for the ESITC
Mar 19, 2025
GU investigator Dr. Parminder Singh leads second team to tackle the Tour de Scottsdale.